PRME
Prime Medicine, Inc. Common Stock
stockNASDAQ
The investment seeks to provide long-term total return. Under normal market conditions, the fund will seek to achieve its investment objective by investing at least 80% of its net assets (including investment borrowings) in U.S. and non-U.S. exchange-traded real estate securities, which includes real estate investment trusts ("REITs"), real estate operating companies ("REOCs") and common stocks or depositary receipts of companies primarily engaged in the real estate industry (collectively, "Real Estate Securities"). It is non-diversified.
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 2.88 | 2026-09-28 | +3.48% | -3.904 |
| 1M | 3.70 | 2026-09-04 | -19.59% | 1.834 |
| 3M | 3.99 | 2026-07-06 | -25.44% | 1.636 |
| 6M | 3.34 | 2026-04-06 | -10.93% | 1.987 |
| 1Y | 6.08 | 2025-10-06 | -51.07% | 2.243 |
| 2Y | 3.51 | 2024-10-04 | -15.24% | — |
| 5Y | 15.76 | 2022-10-21 | -81.12% | 1.930 |
Prime Medicine, Inc. Common Stock (NASDAQ:PRME) stock price today is $2.98, and today's volume is 2,109,997. PRME is down 0.502% today. The 30 day average volume is 3.04M. PRME market cap is $539.60M with 181.38M shares outstanding.